COMMUNIQUÉS West-GlobeNewswire

Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors
03/08/2026
AUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
03/08/2026
Generated second quarter revenue of $200.6 million Second quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14 Second quarter operating cash flow of $23.2 million Announced strategic growth plan designed to [...]
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it [...]
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
03/08/2026
August 3, 2026 – 22:01 PM CEST Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company committed to improving the lives of people suffering from severe autoimmune [...]
Keros Therapeutics Reports Second Quarter 2026 Financial Results
03/08/2026
LEXINGTON, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule
03/08/2026
DRAPER, Utah, Aug. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in [...]
ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026
03/08/2026
Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company [...]
REACT19 Launches $100,000 Matching Campaign as Demand for Medical Grants Surges 33%
03/08/2026
Six families need help today. Fifteen more are already waiting. Every donation through September will be doubled to provide life-saving medical care MEQUON, Wisc., Aug. 03, 2026 (GLOBE NEWSWIRE) -- REACT19 today [...]
A Race Against Blindness Launches New Research Grants Program to Accelerate Treatments for Inherited Retinal Diseases and Bardet-Biedl Syndrome
03/08/2026
New grant program announced at the Bardet-Biedl Syndrome Foundation Annual Conference invites researchers worldwide to apply for funding GILBERT, Ariz., Aug. 03, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness today [...]
Carbios provides an update on the financing of its Longlaville plant project
03/08/2026
Carbios reaffirms its commitment to building the Longlaville plant. Significant milestones have been achieved toward securing the project’s financing. While significant progress has been made, the previously announced [...]
Carbios fait un point d’étape sur le financement de son projet d’usine à Longlaville
03/08/2026
Carbios réaffirme son ambition de construction de l’usine de Longlaville Des étapes importantes en vue de la sécurisation du financement du projet ont été franchies L’objectif annoncé d’un closing d’ici le 30 septembre [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2026
03/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 27th July to 31st July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 31 - 2026
03/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 27 juillet au 31 juillet 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
03/08/2026
Company announcement No. 36 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 31, 2026) Copenhagen, Denmark, August 3, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Corza Medical Expands Gut Suture Portfolio with over 40 New Codes
03/08/2026
New sizes, needle combinations, and configurations strengthen procedural coverage across specialties, giving surgeons more preferred Gut suture options BOULDER, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Corza Medical, a [...]
Cato Healthcare Supply Releases White Paper Introducing Revenue Preservation Procurement™ for Hospital Supply Chains
03/08/2026
Authored by new CEO Ryan F. Zackon, the report draws on more than a decade of global supply chain leadership to provide a new strategic framework for healthcare executives DALLAS, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Cato [...]
Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th
03/08/2026
MIAMI, FL, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results
03/08/2026
Integrated Service Program (ISP) Revenue More Than Doubles Year-over-Year as Gross Margins Expand and Financing Costs Decline West Palm Beach, FL, Aug. 03, 2026 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: [...]
Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation
03/08/2026
Urgent Need for Novel Targets - Recent clinical failure of a competing mechanism highlights urgent need for novel upstream targets, such as 12-LOX, that are being studied to address the root causes of cardio-renal [...]

Pages